Henry Schein (HSIC) PT Bumped to $159 at Piper Jaffray Amid Solid Q4
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Henry Schein Reports Record Fourth Quarter And Full Year Results
February 10, 2016 7:01 AM ESTMELVILLE, N.Y., Feb. 10, 2016 /PRNewswire/ -- Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, today reported record fourth quarter financial results.
Net sales for the quarter ended December 26, 2015 were $2.9 billion, an increase of 5.5% compared with the fourth quarter of 2014. This consisted of 10.3% growth in local currencies and a 4.8% decline related to foreign currency exchange. In local currencies, internally generated sales increased 6.5% and acquisition growth was 3.8% (see Exhibit A for details of sales... More
